Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lyn M Powell"'
Autor:
Jason R Chan, Gregory Vuillaume, Caitlin Bever, Stefan Lebrun, Michael Lietz, Yvonne Steffen, Katrin Stolle, Karim Wahba, Xiao Wang, Shonna Moodie, Julia Hoeng, Manuel C Peitsch, Lyn M Powell
Publikováno v:
BioDiscovery, Vol 3, Iss , Pp 1-13 (2012)
Motivation:Atherosclerosis is a complex multi-pathway inflammatory disease where accumulation of oxidatively modified lipids and leukocytes in the arterial intima leads to plaque formation over time. Translating Apoe-/- mouse results to the clinical
Externí odkaz:
https://doaj.org/article/e87ffa701b074622a23a688c4c0f1401
Autor:
Masood Khaksar Toroghi, Jim Bosley, Lyn M. Powell, Yi Zhang, Feng Yang, Xia Pu, John D. Davis, Nidal Al‐Huniti
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 11, Pp 1332-1342 (2021)
Abstract A model to quantitatively characterize the effect of evinacumab, an investigational monoclonal antibody against angiopoietin‐like protein 3 (ANGPTL3) on lipid trafficking is needed. A quantitative systems pharmacology (QSP) approach was de
Externí odkaz:
https://doaj.org/article/f2c85718b9bd447bb1c865f81dfe8b6c
Autor:
Nidal Al-Huniti, Lyn M Powell, Jim Bosley, Masood Khaksar Toroghi, Feng Yang, Xia Pu, John D. Davis, Yi Zhang
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 11, Pp 1332-1342 (2021)
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology
A model to quantitatively characterize the effect of evinacumab, an investigational monoclonal antibody against angiopoietin‐like protein 3 (ANGPTL3) on lipid trafficking is needed. A quantitative systems pharmacology (QSP) approach was developed t
Autor:
Lyn M Powell, Caitlin A. Bever, Gregory Vuillaume, Julia Hoeng, Shonna Moodie, Yvonne Steffen, Xiao Wang, Jason R Chan, Katrin Stolle, Stefan Lebrun, Michael Lietz, Manuel C. Peitsch, Karim Wahba
Publikováno v:
BioDiscovery, Vol 3, Iss, Pp 1-13 (2012)
BioDiscovery 3: e8929
BioDiscovery 3: e8929
Motivation:Atherosclerosis is a complex multi-pathway inflammatory disease where accumulation of oxidatively modified lipids and leukocytes in the arterial intima leads to plaque formation over time. Translating Apoe-/- mouse results to the clinical
Publikováno v:
Journal of Clinical Investigation. 87:767-771
Elevated plasma levels of lipoprotein(a), Lp(a), represent a major, inherited risk factor for coronary heart disease, although the mechanism of its action remains unknown. Lp(a) is distinguished from the related LDL particle by the addition of apolip
Publikováno v:
FEMS Microbiology Letters. 12:61-64
Autor:
Timothy J. Knott, Stanley C. Rall, Thomas L. Innerarity, Shellie F. Jacobson, Mickey S. Urdea, Beatriz Levy-Wilson, Lyn M. Powell, Richard J. Pease, Roger Eddy, Hiroshi Nakai, Mary Byers, Linda M. Priestley, Elaine Robertson, Leslie B. Rall, Christer Betsholtz, Thomas B. Shows, Robert W. Mahley, James Scott
Publikováno v:
Science. 230:37-43
Apolipoprotein (apo-) B is the ligand responsible for the receptor-mediated catabolism of low density lipoproteins, the principal cholesterol-transporting lipoproteins in plasma. The primary structure of the carboxyl-terminal 30 percent (1455 amino a
Publikováno v:
Moleculargeneral genetics : MGG. 206(1)
The oligopeptide permease is encoded by at least four genes which are transcribed as a single operon. We cloned and characterized this operon from Salmonella typhimurium, as well as the flanking genes, tonB, ana and a new gene, cwd, which affects cel
Publikováno v:
Biochemical Society Transactions. 9:248P-248P